Edition:
United Kingdom

People: Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Capital Market

0.86USD
17 Sep 2019
Change (% chg)

-- (--)
Prev Close
$0.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,361
52-wk High
$4.60
52-wk Low
$0.72

Munshi, Amit 

Mr. Amit D. Munshi is Director of the Company. Mr. Munshi is currently President and CEO of Arena Pharmaceuticals, a biopharmaceutical company developing small molecule therapeutics across a number of important conditions. Mr. Munshi has extensive experience in biotechnology and pharmaceuticals with an over 25 year record of accomplishments. Prior to Arena Pharmaceuticals, Mr. Munshi was previously the CEO of Epirus Biopharmaceuticals and held the same role at Percivia LLC (sold to Johnson & Johnson). From 2005 to 2010, Mr. Munshi was the Chief Business Officer and a co-founder of Kythera Biopharmaceuticals, which was later acquired by Allergan for $2.1 billion. Earlier in his career, Mr. Munshi held roles of increasing responsibility at Amgen globally in multiple product management, general management and corporate development positions. Mr. Munshi holds multiple undergraduate degrees from the University of California, Riverside, and an MBA from The Peter F. Drucker Graduate School at the Claremont Graduate University. Mr Munshi currently serves on the Board of Cytrellis Biosystems, Inc., a privately held company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --